Endosomal Accumulation of Toll-Like Receptor 4 Causes Constitutive Secretion of Cytokines and Activation of Signal Transducers and Activators of Transcription in Niemann–Pick Disease Type C (NPC) Fibroblasts: A Potential Basis for Glial Cell Activation in the NPC Brain

Niemann–Pick disease type C (NPC) is an inherited lipid storage disorder caused by mutations in NPC1 or NPC2 genes. Loss of function of either protein results in the endosomal accumulation of cholesterol and other lipids, progressive neurodegeneration, and robust glial cell activation. Here, we report that cultured human NPC fibroblasts secrete interferon-β, interleukin-6 (IL-6), and IL-8, and contain increased levels of signal transducers and activators of transcription (STATs). These cells also contained increased levels of Toll-like receptor 4 (TLR4) that accumulated in cholesterol-enriched endosomes/lysosomes, and small interfering RNA knockdown of this receptor reduced cytokine secretion. In the NPC1−/− mouse brain, glial cells expressed TLR4 and IL-6, whereas both glial and neuronal cells expressed STATs. Genetic deletion of TLR4 in NPC1−/− mice reduced IL-6 secretion by cultured fibroblasts but failed to alter STAT levels or glial cell activation in the brain. In contrast, genetic deletion of IL-6 normalized STAT levels and suppressed glial cell activation. These findings indicate that constitutive cytokine secretion leads to activation of STATs in NPC fibroblasts and that this secretion is partly caused by an endosomal accumulation of TLR4. These results also suggest that similar signaling events may underlie glial cell activation in the NPC1−/− mouse brain.

[1]  N. Mosaffa,et al.  Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. , 2006, European journal of pharmacology.

[2]  T. Kielian Toll‐like receptors in central nervous system glial inflammation and homeostasis , 2006, Journal of neuroscience research.

[3]  E. Latz,et al.  Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity , 2006, The EMBO journal.

[4]  R. Sundler,et al.  The role of lipid rafts in LPS-induced signaling in a macrophage cell line. , 2006, Molecular immunology.

[5]  Christine M Howison,et al.  Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann‐Pick C mice , 2005, Journal of neuroscience research.

[6]  Christophe Caux,et al.  Recognition of Double-stranded RNA by Human Toll-like Receptor 3 and Downstream Receptor Signaling Requires Multimerization and an Acidic pH* , 2005, Journal of Biological Chemistry.

[7]  G. Lynch,et al.  Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain. , 2005, The American journal of pathology.

[8]  H. Weedon,et al.  Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis , 2005, Annals of the rheumatic diseases.

[9]  JoAnn Buchanan,et al.  Cell-Autonomous Death of Cerebellar Purkinje Neurons with Autophagy in Niemann-Pick Type C Disease , 2005, PLoS genetics.

[10]  S. Walkley,et al.  Consequences of NPC1 and NPC2 loss of function in mammalian neurons. , 2004, Biochimica et biophysica acta.

[11]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[12]  S. Mellon,et al.  Niemann–Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone , 2004, Nature Medicine.

[13]  R. Medzhitov,et al.  Regulation of Phagosome Maturation by Signals from Toll-Like Receptors , 2004, Science.

[14]  L. Guillot,et al.  Response of Human Pulmonary Epithelial Cells to Lipopolysaccharide Involves Toll-like Receptor 4 (TLR4)-dependent Signaling Pathways , 2004, Journal of Biological Chemistry.

[15]  Ryan M. O’Connell,et al.  Toll-like Receptors Induce a Phagocytic Gene Program through p38 , 2004, The Journal of experimental medicine.

[16]  Danielle A. Simmons,et al.  Postnatal development of inflammation in a murine model of Niemann–Pick type C disease: immunohistochemical observations of microglia and astroglia , 2003, Experimental Neurology.

[17]  B. Monks,et al.  Lysines 128 and 132 Enable Lipopolysaccharide Binding to MD-2, Leading to Toll-like Receptor-4 Aggregation and Signal Transduction* , 2003, Journal of Biological Chemistry.

[18]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[19]  Hernan Cardenas,et al.  Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice , 2003, Brain Research.

[20]  L. Ivashkiv,et al.  The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? , 2003, Arthritis and rheumatism.

[21]  Douglas T. Golenbock,et al.  Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction* 210 , 2002, The Journal of Biological Chemistry.

[22]  E. Nanba,et al.  Niemann–Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid β deposition associated with apolipoprotein E ε4 homozygosity , 2002 .

[23]  D. Golenbock,et al.  Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. , 2002, Journal of cell science.

[24]  O. Bernard,et al.  Studies on neuronal death in the mouse model of Niemann‐Pick C disease , 2002, Journal of neuroscience research.

[25]  M. McNiven,et al.  The Antiviral Dynamin Family Member, MxA, Tubulates Lipids and Localizes to the Smooth Endoplasmic Reticulum* , 2002, The Journal of Biological Chemistry.

[26]  P. Gebicke-haerter,et al.  Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  D. German,et al.  Neurodegeneration in the Niemann–Pick C mouse: glial involvement , 2002, Neuroscience.

[28]  K. Higaki,et al.  Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. , 2001, American journal of human genetics.

[29]  K. Higaki,et al.  Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann–Pick C1-deficient cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Ikonen,et al.  Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. , 2001, Journal of cell science.

[31]  M. Scott,et al.  Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. , 2001, Molecular biology of the cell.

[32]  J. Hidalgo,et al.  Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures , 2001, Neuroscience.

[33]  R. Wattiaux,et al.  Identification of HE1 as the second gene of Niemann-Pick C disease. , 2000, Science.

[34]  K. Yamakawa,et al.  Genotype-phenotype relationship of Niemann-Pick disease type C: a possible correlation between clinical onset and levels of NPC1 protein in isolated skin fibroblasts , 2000, Journal of medical genetics.

[35]  K. Takeda,et al.  Cutting Edge: Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages1 , 2000, The Journal of Immunology.

[36]  C. Schindler Cytokines and JAK-STAT signaling. , 1999, Experimental cell research.

[37]  R. Brady,et al.  Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[39]  N. Reich,et al.  Distinct STAT Structure Promotes Interaction of STAT2 with the p48 Subunit of the Interferon-α-stimulated Transcription Factor ISGF3* , 1997, The Journal of Biological Chemistry.

[40]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[41]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[42]  J. Ihle STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[43]  M. Patterson,et al.  PART 16 : LYSOSOMAL DISORDERS Chapter 145 : Niemann-Pick Disease Type C : A Lipid Trafficking Disorder , 2007 .

[44]  R. Proia,et al.  Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. , 2005, Molecular genetics and metabolism.

[45]  S. Murayama,et al.  Cerebellar degeneration in the Niemann-Pick type C mouse , 2004, Acta Neuropathologica.

[46]  B. Ghetti,et al.  Neurofibrillary tangles in Niemann-Pick disease type C , 2004, Acta Neuropathologica.